Dyadic to attend j.p. morgan 42nd annual healthcare conference

Jupiter, fla., jan. 02, 2024 (globe newswire) -- dyadic international, inc. (“dyadic”, or the “company”) (nasdaq: dyai), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable and accessible biopharmaceutical products for human and animal health, and alternative proteins for food, nutrition and wellness, today announced that its management will be attending the following events during the j.p. morgan 42nd annual healthcare conference in january 2024.
DYAI Ratings Summary
DYAI Quant Ranking